How Patients Are Changing Clinical Trials

In September, the Food and Drug Administration (FDA) approved a controversial drug to treat Duchenne muscular dystrophy, a rare but deadly disease that affects boys. That was a reversal from six months earlier, when an FDA advisory committee had recommended against the drug’s approval and said it was not effective, Forbes reported. What tipped the…

The post How Patients Are Changing Clinical Trials appeared first on Next Avenue.

x

Originally posted 2017-05-17 08:15:59.